XML 57 R43.htm IDEA: XBRL DOCUMENT v3.25.1
Discontinued Operations - Narratives (Details) - USD ($)
12 Months Ended
Dec. 27, 2023
Dec. 31, 2023
Dec. 11, 2023
Discontinued Operations      
Fair value of future payments   $ 1,720,000  
Gain on sale of discontinued operations   $ 1,467,451  
Discontinued Operations, Disposed of by Sale | Elusys Therapeutics      
Discontinued Operations      
Purchase price $ 2,488,000    
Cash received 500,000   $ 500,000
Contingent consideration receivable $ 300,000    
Duration of convertible note 1 year    
Fair value of future payments $ 1,720,000    
Gain on sale of discontinued operations $ 1,467,451